"This type of gene editing should also allow for the treatment of diseases whose origin is not genetic or whose origin cannot ...

During the COVID-19 pandemic, health worker Maria Tereza Malheiros Sapienza's curiosity was aroused by her immunity to ...

Researchers at Tel Aviv University have achieved a breakthrough in drug delivery: they have successfully transported lipid ...

Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

Robert F. Kennedy Jr., the HHS secretary nominee, has said he is not antivaccine, but he has a track record of casting doubt ...

January 2025 marks five years since the beginning of the COVID-19 pandemic that resulted in 1,216,305 American deaths and ...

Even though people may be getting better at fighting the illness, COVID-19 is still dangerous to vulnerable groups. And so ...

Fintel reports that on January 28, 2025, BTIG initiated coverage of Arcturus Therapeutics Holdings (NasdaqGM:ARCT) with a Buy ...

Scientists at the University of São Paulo analyzed blood samples donated by six serodiscordant couples where female partners ...

Bats carry viral pathogens that typically do not lead to severe disease in the bats themselves but can be lethal to humans. Adaptations in certain immune genes might contribute to this resistance.

Learn more about whether Twist Bioscience Corporation or Veracyte, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Legend Biotech Corporation or Twist Bioscience Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.